2.75 (-%)
As of Nov 21, 2024
Source:
Relmada Therapeutics, Inc. is a clinical-stage, publicly traded biotechnology company developing NCEs that potentially address areas of high unmet medical need in the treatment of depression and other CNS diseases.
| Country | United States |
| Headquarters | coral gables, florida |
| Phone Number | (786) 629 1376 |
| Industry | manufacturing |
| CEO | Sergio Traversa |
| Website | www.relmada.com |